Please read the news briefing at your natural speed. Thank you!
The Financial Times | Briefing | August 27
Bristol-Myers and Celgene progress
The $90bn merger between the pharma groups has taken a step towards regulatory approval after Celgene agreed the sale of its psoriasis drug Otezla to rival Amgen for $13.4bn in cash.
China storm over US federal pension fund
Top senators have demanded that one of the largest retirement funds reverse a planned portfolio shift that they say will aid China’s military and spying efforts by funding companies involved.
Five Star grass roots warn over coalition
Activists from the populist Italian group have threatened to desert if its leaders seal a deal with the Democratic party, which they see as an element of the discredited establishment.
Slain Malta journalist’s family hits at UK
Relatives of Daphne Caruana Galizia, who was investigating political corruption allegations when she was murdered, have said Britain has not done enough to seek justice.
Gloom deepens over German economy
A survey of business leaders this month has found that sentiment has sunk to its lowest level in seven years, the fifth consecutive month of increasing pessimism.
Brazilian business joins Amazon outcry
Top companies and trade groups have added their voice to global concerns over the forest fires, fearing boycotts as environmentally conscious buyers turn away from the country’s produce.
Facial recognition group eyes HK listing
Megvii, one of China’s top two facial recognition companies, has filed for a listing in which it will seek to raise as much as $1bn, braving a market pummelled by trade tensions and protests.